A citation-based method for searching scientific literature

Vera A Bittner, Michael Szarek, Philip E Aylward, Deepak L Bhatt, Rafael Diaz, Jay M Edelberg, Zlatko Fras, Shaun G Goodman, Sigrun Halvorsen, Corinne Hanotin, Robert A Harrington, J Wouter Jukema, Virginie Loizeau, Patrick M Moriarty, Angèle Moryusef, Robert Pordy, Matthew T Roe, Peter Sinnaeve, Sotirios Tsimikas, Robert Vogel, Harvey D White, Doron Zahger, Andreas M Zeiher, Ph Gabriel Steg, Gregory G Schwartz. J Am Coll Cardiol 2020
Times Cited: 150

Pia R Kamstrup, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2014
Times Cited: 301

List of shared articles

Times cited

Florian Kronenberg. Handb Exp Pharmacol 2022

Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview.
Ioannis Parthymos, Michael S Kostapanos, Dimitri P Mikhailidis, Matilda Florentin. Eur J Prev Cardiol 2022

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Gissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, P Barton Duell, Sean P Heffron, Pia R Kamstrup, Donald M Lloyd-Jones, Santica M Marcovina, Calvin Yeang, Marlys L Koschinsky. Arterioscler Thromb Vasc Biol 2022

Therapeutic RNA-silencing oligonucleotides in metabolic diseases.
Algera Goga, Markus Stoffel. Nat Rev Drug Discov 2022

Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease.
David A Rider, Mona Eisermann, Kathrin Löffler, Manuela Aleku, Daniel I Swerdlow, Sibylle Dames, Judith Hauptmann, Eliot Morrison, Marie Wikström Lindholm, Steffen Schubert,[...]. Atherosclerosis 2022

Association Between Lipoprotein(a) and Calcific Aortic Valve Disease: A Systematic Review and Meta-Analysis.
Qiyu Liu, Yanqiao Yu, Ruixi Xi, Jingen Li, Runmin Lai, Tongxin Wang, Yixuan Fan, Zihao Zhang, Hao Xu, Jianqing Ju. Front Cardiovasc Med 2022

Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review.
Freddy Duarte Lau, Robert P Giugliano. JAMA Cardiol 2022

Considerations for routinely testing for high Lp(a).
Nick S Nurmohamed, Patrick M Moriarty, Erik S G Stroes. Curr Opin Lipidol 2022

Lipoprotein(a): Expanding our knowledge of aortic valve narrowing.
Amer Youssef, Justin R Clark, Marlys L Koschinsky, Michael B Boffa. Trends Cardiovasc Med 2021

Recent Updates of Lipoprotein(a) and Cardiovascular Disease.
Taili Liu, Won-Sik Yoon, Sang-Rok Lee. Chonnam Med J 2021

Drugs for Prevention and Treatment of Aortic Stenosis: How Close Are We?
Mehdi Afshar, Shayan Yazdan-Ashoori, James C Engert, George Thanassoulis. Can J Cardiol 2021

The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently?
Marcio H Miname, Viviane Z Rocha, Raul D Santos. Curr Atheroscler Rep 2021

Lipoprotein (a): Recent Updates on a Unique Lipoprotein.
Anum Saeed, Sina Kinoush, Salim S Virani. Curr Atheroscler Rep 2021

Lipoprotein (a): When to Measure and How to Treat?
David Rhainds, Mathieu R Brodeur, Jean-Claude Tardif. Curr Atheroscler Rep 2021

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis.
Chih-Kuo Lee, Che-Wei Liao, Shih-Wei Meng, Wei-Kai Wu, Jiun-Yang Chiang, Ming-Shiang Wu. Biomedicines 2021